| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/13543784.11.3.357 |
| P698 | PubMed publication ID | 11866665 |
| P50 | author | Enrico Carmina | Q91748925 |
| P2860 | cites work | A novel use of spironolactone: treatment of hirsutism | Q34286749 |
| Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: Efficacy, metabolic and endocrine effects | Q34297365 | ||
| Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy | Q34340770 | ||
| Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome | Q34473103 | ||
| Cyproterone acetate for severe hirsutism:results of a double-blind dose-ranging study | Q34759344 | ||
| The clinical development of a 5α-reductase inhibitor, finasteride | Q36611087 | ||
| Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism | Q39743870 | ||
| Finasteride | Q40384709 | ||
| Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate | Q42204132 | ||
| Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist | Q42456299 | ||
| The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome | Q42504903 | ||
| Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin | Q42513501 | ||
| Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism | Q42543416 | ||
| Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients | Q44734062 | ||
| Side-effects of spironolactone therapy in the hirsute woman | Q45233568 | ||
| Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues | Q48368446 | ||
| Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. | Q50895589 | ||
| Do hyperandrogenic women with normal menses have polycystic ovary syndrome? | Q51565215 | ||
| The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism. | Q51624394 | ||
| External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor. | Q52240961 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hirsutism | Q1620594 |
| P304 | page(s) | 357-363 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Expert Opinion on Investigational Drugs | Q5421208 |
| P1476 | title | Anti-androgens for the treatment of hirsutism | |
| P478 | volume | 11 |
| Q44444513 | Anticonvulsant Effect of Flutamide on Seizures Induced by Pentylenetetrazole: Involvement of Benzodiazepine Receptors |
| Q33323282 | Assessment, diagnosis and treatment of a patient with hirsutism |
| Q39209037 | Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome |
| Q47136214 | Effect of spironolactone on pain responses in mice |
| Q35685428 | Genetic and environmental aspect of polycystic ovary syndrome |
| Q36301573 | Insulin-sensitisers in the treatment of polycystic ovary syndrome |
| Q35906966 | Recent advances in the treatment of polycystic ovary syndrome |
| Q44084386 | Treatment of polycystic ovary syndrome with insulin-lowering agents |
Search more.